ScholarIQanswers from OpenAlex & ORCID
Anna Forsythe
ResearcherPublications, citations & collaboration network
Anna Forsythe is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anna Forsythe have?
ScholarIQindexed works
Anna Forsythe has 179 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anna Forsythe have?
ScholarIQcitation count
Anna Forsythe has 1,365 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anna Forsythe?
ScholarIQh-index
Anna Forsythe has an h-index of 20 in OpenAlex.
What is the i10-index of Anna Forsythe?
ScholarIQi10-index
Anna Forsythe has an i10-index of 31 in OpenAlex.
What is the ORCID of Anna Forsythe?
ScholarIQorcid
The ORCID for Anna Forsythe is on the source record.
What is the OpenAlex record for Anna Forsythe?
ScholarIQopenalex
The OpenAlex for Anna Forsythe is on the source record.
What are the most-cited papers on Anna Forsythe?
ScholarIQmost cited works
Chronic gout: epidemiology, disease progression, treatment and disease burden
Richard A. Brook, Anna Forsythe, James E. Smeeding, N. Lawrence Edwards
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Anna Forsythe, Wei Zhang, U.P. Strauss, Marc Fellous, Maesumeh Korei, Karen Keating
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy
N. Lawrence Edwards, John S. Sundy, Anna Forsythe, Steven W. Blume, Faming Pan, Michael A. Becker
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Javier Cortés, Stacie Hudgens, Chris Twelves, Edith A. Perez, Ahmad Awada, Louise Yelle, Susan McCutcheon, Peter A. Kaufman, Anna Forsythe, Galina Velikova
Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
Vibeke Strand, Dinesh Khanna, Jasvinder A. Singh, Anna Forsythe, N. Lawrence Edwards